Besides these observations in human samples, the blockade of CTLA-4 in an immune-competent mouse model of HNSCC significantly reduced MDSCs, M2 macrophages, and tumor burden while improving the effector function of T cells [67]. This evidence concerns the gene CTLA4 and neoplasm.